Lack of Effect of Cenerimod, a Selective S1P(1) Receptor Modulator, on the Pharmacokinetics of a Combined Oral Contraceptive

Cenerimod, a sphingosine-1-phosphate 1 receptor modulator, is in development for the treatment of systemic lupus erythematosus, a disease mainly affecting women of childbearing potential. The effect of cenerimod on the pharmacokinetics (PK) of a combined oral contraceptive (COC, 100 µg levonorgestre...

Descripción completa

Detalles Bibliográficos
Autores principales: Juif, Pierre-Eric, Mueller, Markus S., Charfi, Hakim, Dingemanse, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736746/
https://www.ncbi.nlm.nih.gov/pubmed/36499313
http://dx.doi.org/10.3390/ijms232314986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736746/
https://www.ncbi.nlm.nih.gov/pubmed/36499313
http://dx.doi.org/10.3390/ijms232314986

Ejemplares similares